Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
ally bridge group
asthma
beth seidenberg
big data analytics
biotech
blackrock
boston
boston blog main
boston top stories
casdin capital
clinical trials
diabetic nephropathy
eventide asset management
focal segmental glomerulosclerosis
goldfinch bio
irving investors
jay ghosh
kleiner perkins caufield & byers
kpcb
life sciences
national blog main
national top stories
pain
schroeder adveq
software
tc
third rock ventures
wellington management company
yonjin capital
What
biotech
2
×
bring
develop
2
×
drug
2
×
analysis
announce
asthma
beth
bio
byers
capitalism
caufield
companies
company
diseases
disrupt
drugs
employing
exits
genetic
goldfinch
helped
immunologist
ipo
kidney
kleiner
kpcb
later
lead
led
licensed
m.d
market
medication
medicines
million
new
pain
partner
perkins
Language
unset
Current search:
biotech
×
drug
×
develop
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@techcrunch.com
8 years ago
M.D. Turned VC Beth Seidenberg To Talk Biotech Startups At Disrupt SF
